» Articles » PMID: 31935210

Naturally Occurring Sclareol Diterpene Augments the Chemosensitivity of Human Hela Cervical Cancer Cells by Inducing Mitochondrial Mediated Programmed Cell Death, S-Phase Cell Cycle Arrest and Targeting Mitogen-Activated Protein Kinase...

Overview
Journal Med Sci Monit
Date 2020 Jan 15
PMID 31935210
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

BACKGROUND Cervical cancer is a major threat to female health worldwide. This study was performed to study the anticancer potential of sclareol and as a chemo-sensitizing agent against human cervical cancer cells along with evaluating its effects on apoptosis, cell cycle arrest, and MAPK/ERK signaling pathway. MATERIAL AND METHODS MTT assay was performed to check cell viability, morphological changes were observed through phase-contrast microscopy, DAPI (4',6-diamidino-2-phenylindole) staining and TUNEL (terminal deoxynucleotidyl transferase dUTP nick end labelling) assays were performed to evaluate apoptotic effects; MMP (matrix metalloproteinase) and cell cycle analysis were examined through flow cytometry. Western blotting analysis was performed to check the protein expressions of MAPK/ERK signaling pathway and apoptosis proteins. RESULTS Results depicted that both sclareol and cisplatin induced cytotoxic effects individually but when used in combination, it led to much more pronounced cytotoxic effects indicating a synergistic effect of sclareol on cisplatin. Sclareol treatment led to significant decrease in the levels of p-MEK and p-ERK. Significant morphological changes (including chromatin condensation, nuclear fragmentation) in cervical cancer cells were seen after treatment. Western blot showed significant alterations including increase in BAX and decrease in BCL-2 levels. An increase in the S-phase cells, indicating cell cycle arrest at S-phase was seen along with modulating the expressions of CDK-1and Cdc25C, and increase in the levels of p-CDK-1, cyclin-B1, cyclin-A, and p-Cdc25C. CONCLUSIONS Sclareol not only induced cytotoxic effects but also enhanced chemosensitivity of human cervical cancer cells towards cisplatin and these effects are mediated via MAPK/ERK signaling pathway, stimulation of apoptosis and S-phase cell cycle arrest.

Citing Articles

Retracted: Naturally Occurring Sclareol Diterpene Augments the Chemosensitivity of Human Hela Cervical Cancer Cells by Inducing Mitochondrial Mediated Programmed Cell Death, S-Phase Cell Cycle Arrest and Targeting Mitogen-Activated Protein Kinase....

Li W, Ping Z, Xuemei G, Minglian L, Hongjuan M, Yi H Med Sci Monit. 2021; 27:e932350.

PMID: 33762566 PMC: 8009260. DOI: 10.12659/MSM.932350.


L. Essential Oil Extract and Its Antioxidative Phytochemical Sclareol Inhibit Oxytocin-Induced Uterine Hypercontraction Dysmenorrhea Model by Inhibiting the Ca-MLCK-MLC20 Signaling Cascade: An Ex Vivo and In Vivo Study.

Wong J, Chiang Y, Shih Y, Chiu C, Chen H, Shieh T Antioxidants (Basel). 2020; 9(10).

PMID: 33066489 PMC: 7602146. DOI: 10.3390/antiox9100991.


TRAF6 Promotes Gastric Cancer Cell Self-Renewal, Proliferation, and Migration.

Yang M, Jin M, Li K, Liu H, Yang X, Zhang X Stem Cells Int. 2020; 2020:3296192.

PMID: 32724313 PMC: 7382744. DOI: 10.1155/2020/3296192.


Identification of Prognostic miRNA Signature and Lymph Node Metastasis-Related Key Genes in Cervical Cancer.

Chen S, Gao C, Wu Y, Huang Z Front Pharmacol. 2020; 11:544.

PMID: 32457603 PMC: 7226536. DOI: 10.3389/fphar.2020.00544.

References
1.
Bentivegna E, Gouy S, Maulard A, Chargari C, Leary A, Morice P . Oncological outcomes after fertility-sparing surgery for cervical cancer: a systematic review. Lancet Oncol. 2016; 17(6):e240-e253. DOI: 10.1016/S1470-2045(16)30032-8. View

2.
Salihi R, Leunen K, Van Limbergen E, Moerman P, Neven P, Vergote I . Neoadjuvant chemotherapy followed by large cone resection as fertility-sparing therapy in stage IB cervical cancer. Gynecol Oncol. 2015; 139(3):447-51. DOI: 10.1016/j.ygyno.2015.05.043. View

3.
Dargent D, Martin X, Sacchetoni A, Mathevet P . Laparoscopic vaginal radical trachelectomy: a treatment to preserve the fertility of cervical carcinoma patients. Cancer. 2000; 88(8):1877-82. View

4.
Butler M . The role of natural product chemistry in drug discovery. J Nat Prod. 2004; 67(12):2141-53. DOI: 10.1021/np040106y. View

5.
Beiner M, Covens A . Surgery insight: radical vaginal trachelectomy as a method of fertility preservation for cervical cancer. Nat Clin Pract Oncol. 2007; 4(6):353-61. DOI: 10.1038/ncponc0822. View